Health and Fitness

NIH Summit

NIH Summit Delivers Recommendations to Accelerate Therapy Development for Alzheimer’s Disease

Call for transformative research agenda, open and collaborative science, to enable precision medicine. Bethesda, Maryland—(ENEWSPF)—May 25, 2018 Contact:  Joe Balintfy Experts from government, academia, industry, and non-profit organizations put forward recommendations that provide a roadmap for an integrated, multidisciplinary research agenda necessary to inform priorities for Alzheimer’s disease and related[Read More…]

Depression in African Americans

African Americans and Latinos are More Likely to be at Risk for Depression than Whites

Bethesda, Maryland—(ENEWSPF)—May 25, 2018 Contact: Rebecca Newton A new study published in the May 2018 issue of Preventive Medicine (link is external) shows that African Americans and Latinos are significantly more likely to experience serious depression than Whites, but chronic stress does not seem to explain these differences. Dr. Eliseo[Read More…]

Medical procedures

Trump-Pence Domestic Gag Rule Would Deny Millions of Women Access to Health Care and the Ability to Make Medically Informed Decisions

Washington, D.C. —(ENEWSPF)—May 24, 2018 By: Jamila Taylor Last night, the Trump administration issued a proposed rule that viciously targets Title X providers, including Planned Parenthood and the millions of women served by the program. Jamila Taylor, a senior fellow at the Center for American Progress, issued the following statement[Read More…]

Teething baby

FDA Takes Action Against the Use of Over-the-counter Benzocaine Teething Products

Agency urges companies to discontinue teething products, include new warnings for other OTC benzocaine products and revise warnings for approved prescription local anesthetic drugs Silver Spring, Maryland—(ENEWSPF)—May 24, 2018 Contact: Sandy Walsh The U.S. Food and Drug Administration is warning consumers that over-the-counter (OTC) teething products containing benzocaine pose a[Read More…]

FDA

FDA Approves New Drug for Patients with Chronic Liver Disease and Low Blood Platelets and Undergoing a Medical Procedure

Silver Spring, Maryland—(ENEWSPF)—May 21, 2018 Contact: Sandy Walsh The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the[Read More…]

Healthcare for undocumented

Choosing Between Death And Deportation

What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices. CALIFORNIA—(ENEWSPF)—May 21, 2018 By: Dan Gorenstein “Dear the most highly respected judge and court, I’m[Read More…]

Paul Ryan et al

Health Care Sabotage Will Increase Insurance Premiums by More Than $1,000 Next Year

Washington, D.C. —(ENEWSPF)—May 18, 2018 By: Thomas Huelskoetter Today, the Center for American Progress released a new 50-state analysis projecting the average increase in insurance premiums for a 40-year-old marketplace shopper for the 2019 plan year. The analysis accounts for both the impact of repealing the Affordable Care Act’s individual mandate[Read More…]

Aimovig

FDA Approves Novel Preventive Treatment for Migraine in Adults

Silver Spring, Maryland—(ENEWSPF)—May 18, 2018 Contact: Sandy Walsh The U.S. Food and Drug Administration (FDA) approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by[Read More…]

Medicae Part D Enrollment

Three Firms Account for Over Half of All Medicare Part D Enrollees in 2018

Pending Mergers Would Further Consolidate the Marketplace California—(ENEWSPF)—May 17, 2018 By: Juliette Cubanski, Anthony Damico, and Tricia Neuman In 2018, three Medicare Part D plan sponsors—UnitedHealth, Humana, and CVS Health—account for more than half of the program’s 43 million Part D enrollees (55 percent) and two-thirds of all stand-alone drug plan[Read More…]

Most read stories this week

Take a Survey

ARCHIVES